-
EP3700580
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3700580
| EP3700580 - IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN- (FAP- ) [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 24.02.2023 Database last updated on 02.09.2024 | |
| Former | Request for examination was made Status updated on 31.07.2020 | ||
| Former | The international publication has been made Status updated on 04.05.2019 | Most recent event Tooltip | 31.07.2024 | New entry: Reply to examination report | Applicant(s) | For all designated states The Johns Hopkins University 3400 North Charles Street Baltimore, MD 21218 / US | [2020/36] | Inventor(s) | 01 /
YANG, Xing 909 W. University Parkway Apt 301 Baltimore Maryland 21210 / US | 02 /
NIMMAGADDA, Sridhar 800 Leadenhall St. Baltimore Maryland 21230 / US | 03 /
ROWE, Steven 7 Tadmore Ct. Apt. 304 Parkville Massachusetts 21234 / US | 04 /
SLANIA, Stephanie 182 E. Centre St. Baltimore Maryland 21202 / US | 05 /
POMPER, Martin G. 101 Churchwardens Road Baltimore Maryland 21212 / US | [2020/36] | Representative(s) | Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB | [N/P] |
| Former [2020/36] | Murgitroyd & Company Murgitroyd House 165-169 Scotland Street Glasgow G5 8PL / GB | Application number, filing date | 18871298.8 | 23.10.2018 | [2020/36] | WO2018US57086 | Priority number, date | US201762575607P | 23.10.2017 Original published format: US 201762575607 P | [2020/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2019083990 | Date: | 02.05.2019 | Language: | EN | [2019/18] | Type: | A2 Application without search report | No.: | EP3700580 | Date: | 02.09.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.05.2019 takes the place of the publication of the European patent application. | [2020/36] | Search report(s) | International search report - published on: | KR | 13.06.2019 | (Supplementary) European search report - dispatched on: | EP | 20.05.2021 | Classification | IPC: | A61K51/04, C07D403/14, A61K49/00 | [2021/25] | CPC: |
C07D403/14 (EP,EA,IL);
A61K51/0455 (EP,CN,EA,IL,KR);
A61K49/0032 (EP,CN,EA,IL);
A61K51/0485 (US);
A61K47/545 (CN,US);
A61K49/0052 (EP,CN,EA,IL);
A61K51/0474 (KR);
A61K51/0478 (CN,US);
A61K51/0482 (CN,US);
A61K51/0497 (EP,CN,EA,IL,KR);
A61P29/00 (CN);
A61P35/00 (CN);
A61P43/00 (CN);
A61P5/00 (CN);
A61P7/04 (CN);
C07D401/14 (CN);
A61K2121/00 (KR);
A61K2123/00 (KR);
C07B2200/07 (CN)
(-)
|
| Former IPC [2020/36] | A61K51/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/36] | Title | German: | GEGEN FIBROBLASTENAKTIVIERUNGSPROTEIN (FAP) BILDGEBUNGS- UND RADIOTHERAPEUTIKA | [2020/36] | English: | IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING FIBROBLAST-ACTIVATION PROTEIN- (FAP- ) | [2020/36] | French: | AGENTS D'IMAGERIE ET DE RADIOTHÉRAPIE CIBLANT LA PROTÉINE- D'ACTIVATION DES FIBROBLASTES (FAP- ) | [2020/36] | Entry into regional phase | 21.04.2020 | National basic fee paid | 21.04.2020 | Search fee paid | 21.04.2020 | Designation fee(s) paid | 21.04.2020 | Examination fee paid | Examination procedure | 21.04.2020 | Examination requested [2020/36] | 16.12.2021 | Amendment by applicant (claims and/or description) | 04.03.2022 | Observations by third parties | 27.02.2023 | Despatch of a communication from the examining division (Time limit: M06) | 11.09.2023 | Reply to a communication from the examining division | 10.01.2024 | Observations by third parties | 29.01.2024 | Despatch of a communication from the examining division (Time limit: M06) | 29.07.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 27.10.2020 | Renewal fee patent year 03 | 27.10.2021 | Renewal fee patent year 04 | 27.10.2022 | Renewal fee patent year 05 | 27.10.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2014001538 (GE HEALTHCARE LTD [GB]); | [XI]WO2015114166 (PHILOCHEM AG [CH]); | [A]WO2016149188 (UNIV JOHNS HOPKINS [US]) | International search | [A]US2008280856 (COHEN FREDERICK [US], et al); | [A]US2014357650 (JANSEN KOEN [BE], et al); | other | WO2019154886 | WO2010014933 | WO2010108125 | WO2013107820 | WO2016065142 | WO2016196628 |